Introduction: Oxidation and inflammation, a molecular link between non-communicable diseases

Advances in Experimental Medicine and Biology

Volumn 824, Issue , 2014, Pages 1-4

  Camps, Jordi ^a   García Heredia, Anabel ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Inflammation; Metabolism; Non communicable diseases; Oxidation

Indexed keywords

ACYL COENZYME A DESATURASE; ADVANCED GLYCATION END PRODUCT; ARYLDIALKYLPHOSPHATASE; MONOCYTE CHEMOTACTIC PROTEIN 1;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISORDER; MORBIDITY; MORTALITY; NEOPLASM; NEUROLOGIC DISEASE; NON COMMUNICABLE DISEASE; OBESITY; OXIDATION; OXIDATION KINETICS; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL INACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 84934434786     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-7320-0_1     Document Type: Review

References (29)

1. Ebrahim S, Pearce N, Smeeth L, Casas JP, Jaffar S, Piot P. Tackling non-communicable diseases in lowand middle-income countries: is the evidence from high-income countries all we need? PLoS Med. 2013;10:e1001377.
2. Mensah GA, Mayosi BM. The 2011 United Nations high-level meeting on non-communicable diseases: the Africa agenda calls for a 5-by-5 approach. S Afr Med J. 2012;103:77-9.
3. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313-8.
4. De Ferranti S, Mozaffarian S. The perfect storm: obesity, adipocyte dysfunction and metabolic consequences. Clin Chem. 2008;54:945-55.
5. Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediat Inflamm. 2010. doi: 10.1155/2010/326580, pii: 326580.
6. Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-83.
7. Vinaixa M, Rodríguez MA, Rull A, Beltrán R, Bladé C, Brezmes J, et al. Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res. 2010;9:2527-38.
8. Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta. 1817; 2012:1833-8.
9. Camps J, Rodríguez-Gallego E, García-Heredia A, Triguero I, Riera-Borrull M, Hernández-Aguilera A, et al. Adv Clin Chem. 2014;63:247-308.
10. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the evidence. Lancet. 2007;370:1939-46.
11. Ferré N, Feliu A, García-Heredia A, et al. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome. Clin Biochem. 2013;46:1830-6.
12. Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK. The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism. Int J Mol Sci. 2012;13:10478-504.
13. Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab. 2012;26:711-23.
14. Arduíno DM, Esteves AR, Cardoso SM. Mitochondria drive autophagy pathology via microtubule disassembly: a new hypothesis for Parkinson disease. Autophagy. 2013;9:112-4.
15. Enache I, Charles AL, Bouitbir J, Favret F, Zoll J, Metzger D, et al. Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension. Mol Cell Biochem. 2013;373:161-70.
16. Medina-Gómez G. Mitochondria and endocrine function of adipose tissue. Best Pract Res Clin Endocrinol Metab. 2012;26:791-804.
17. Ouyang J, Wu M, Huang C, Cao L, Li G. Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: involvement of mitochondrial apoptotic pathways. Oncol Rep. 2013;29:79-86.
18. Pagano G, Castello G, Pallardó FV. Sjøgren's syndrome- associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials. Free Rad Res. 2013;47:71-3.
19. Masana L, Camprubi M, Sarda P, Sola R, Joven J, Turner PR. The Mediterranean-type diet: is there a need for further modification? Am J Clin Nutr. 1991;53:886-9.
20. Paul A, Calleja L, Camps J, Osada J, Vilella E, Ferré N, et al. The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sci. 2000;68:457-65.
21. Rius B, López-Vicario C, González-Périz A, Morán- Salvador E, García-Alonso V, Clària J, Titos E, et al. Resolution of inflammation in obesity-induced liver disease. Front Immunol. 2012;3:257.
22. Rogge MM. The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs. 2009; 10:356-73.
23. Mirza MS. Obesity, visceral fat and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011;2011: 11 p. 592404.
24. Tous M, Ferré N, Rull A, Marsillach J, Coll B, Alonso-Villaverde C, et al. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun. 2006; 340:1078-84.
25. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009;46:83-106.
26. Vanden Heuvel JP. Nutrigenomics and nutrigenetics of 3 polyunsaturated fatty acids. Prog Mol Biol Transl Sci. 2012;108:75-112.
27. Rodríguez-Gallego E, Riera-Borrull M, Hernández- Aguilera A, Mariné-Casadó R, Rull A, Beltrán- Debón R, et al. Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation. Mediators Inflamm. 2013;2013:953841.
28. Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411-29.
29. Lowe FJ, Luettich K, Gregg EO. Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective. Biomarkers. 2013;18:183-95.